Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18326568

Adding pharmacogenetics information to drug labels: lessons learned

Author
HAGA, Susanne B1 ; THUMMEL, Kenneth E2 ; BURKE, Wylie2
[1] Institute for Genome Sciences & Policy, Duke University, Durham, North Carolina, United States
[2] Department of Pharmaceutics, University of Washington and Department of Medical History and Ethics, University of Washington Seattle, Washington, United States
Source

Pharmacogenetics and genomics (Print). 2006, Vol 16, Num 12, pp 847-854, 8 p ; ref : 57 ref

ISSN
1744-6872
Scientific domain
Genetics; Pharmacology drugs
Publisher
Lippincott Williams and Wilkins, Hagerstown, MD
Publication country
United States
Document type
Article
Language
English
Author keyword
6-mercaptopurine FDA TPMT UGT1A1 cancer clinical utility drug labels irinotecan
Keyword (fr)
Anticancéreux Information Irinotécan Médicament Pharmacogénétique Tumeur maligne Cancer
Keyword (en)
Antineoplastic agent Information Irinotecan Drug Pharmacogenetics Malignant tumor Cancer
Keyword (es)
Anticanceroso Información Irinotecán Medicamento Farmacogenética Tumor maligno Cáncer
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02A General pharmacology / 002B02A05 Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions

Discipline
General pharmacology
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
18326568

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web